Exact Sciences Announces Fourth-Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Exact Sciences (EXAS) Tops Q4 Revenue View
February 11, 2020 4:12 PM ESTExact Sciences (NASDAQ: EXAS) reported Q4 EPS of $0.56, which includes items and does not compare to the analyst estimate of ($0.35). Revenue for the quarter came in at $295.6 million versus the consensus estimate of $283.05 million.
"The Exact Sciences team delivered another strong... More
